Cardiac amyloidosis (CA) is caused by extracellular myocardial deposition of amyloid fibrils
that are primary derived either from misfolding of transthyretin (ATTR) or light-chain (AL) …

Cardiac amyloidosis (CA) is a restrictive disease that results from intramyocardial amyloid
deposition due to immunoglobulin light chain or transthyretin proteins. Up to two-third of CA …

Aims The study aimed to investigate the prevalence, phenotypic characteristics, and
predictors of atrial fibrillation (AF) in patients presenting with cardiac amyloidosis (CA) of …

Stroke in young adults is associated with significant morbidity, and its prevalence is rising in
the United States. This is partly attributed to a rise in the prevalence of traditional risk factors …

Transthyretin amyloidosis (ATTR) is a group of diseases caused by the deposition of
insoluble fibrils derived from misfolded transthyretin, which compromises the structure and …

Cardiac amyloidosis (CA) is an underdiagnosed disease that is caused by deposition of
misfolded transthyretin (ATTR) or immunoglobulin light chain (AL) fibrils in the myocardium …

Cardiac amyloidosis (CA) is caused by deposition of amyloid fibrils in the myocardium and
has two main subtypes, transthyretin cardiac amyloidosis (ATTR) and immunoglobulin light …

Background: In cardiac amyloidosis, the prevalence of thromboembolic events and atrial
fibrillation is higher in transthyretin amyloidosis compared to immunoglobulin light chain …

Background: Transthyretin cardiac amyloidosis (ATTR-CA) is an increasingly recognized
disease, in which atrial fibrillation (AF) has been shown to be prevalent. Cardiac …

Cardiac amyloidosis is caused by amyloid fibrils that deposit in the myocardial interstitium,
causing restrictive cardiomyopathy and eventually death. The electromechanical …